Yüklüyor......
32.1 PHARMACOTHERAPY TRIALS FOR CIAS: A BRIEF HISTORY AND CONSIDERATIONS FOR THE FUTURE
BACKGROUND: Cognitive impairment is common in people with schizophrenia and is among the strongest predictors of functional decline in this patient group. Despite considerable efforts, there are however no pharmacological treatments for cognitive impairment associated with schizophrenia (CIAS) that...
Kaydedildi:
| Yayımlandı: | Schizophr Bull |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6455195/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sbz022.132 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|